Revisión web de parexel.com
CRO & Biopharmaceutical Services | Parexel
Generado el 07 Marzo 2026 21:15 PM
Resultados antiguos? ACTUALIZAR !
La puntuación es 60/100
Contenido SEO
Título
CRO & Biopharmaceutical Services | Parexel
Longitud : 42
Perfecto, tu título contiene entre 10 y 70 caracteres.
Descripción
For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.
Longitud : 129
Genial, tu descripción meta contiene entre 70 y 160 caracteres.
Palabras Claves (Keywords)
biopharmaceutical services
Bien, tu página contiene palabras clave (meta keywords).
Propiedades Meta Og
Esta página no usa etiquetas Og. Estas etiquetas permiten a los rastreadores sociales estructurar mejor tu página. Usa este generador de etiquetas og gratuito para crearlas.
Titulos
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 2 | 51 | 8 | 32 | 0 |
- [H1] Who we are,
- [H2] While running a triathlon, Andrea stumbled and realized something was wrong.
- [H2] Parexel is proudly among the world’s largest clinical research organizations
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] She thought it was just an injury. Her hamstrings were tight, and her body felt stiff and slow.
- [H3] She had ALS, a condition affecting more than 200,000 people around the world.
- [H3] Her life expectancy was shortened to just two to five years — but she was determined to make the most of it.
- [H3] Andrea continued to join triathlons, even as she underwent treatment in a clinical trial, inspiring many and raising $1,000,000 for ALS research.
- [H3] Today, alive beyond her original prognosis, she serves on our Patient Advisory Council, using her experiences to help improve our neuroscience trials.
- [H3] Lives can change when you design neuroscience trials with speed and precision.
- [H3] We focus on patients, because they inspire us to deliver better trials, faster than ever. So we can make a difference for more patients everywhere.
- [H4]
- [H4] Oncology
- [H4] I&I
- [H4] Cell & Gene Therapy
- [H4] Endocrine & Metabolic
- [H4] Resources
- [H4] Regional Websites
- [H4] Quick Links
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
Imagenes
Hemos encontrado 23 imágenes en esta web.
Bien, la mayoría de tus imágenes tienen atributo alt.
Ratio Texto/HTML
Ratio : 24%
Bien, el ratio entre texto y código HTML de esta página es mayor que 15, pero menor que 25 por ciento.
Flash
Perfecto, no se ha detectado contenido Flash en la página.
Iframe
Muy mal, tienes Iframes en la página, esto significa que el contenido no podrá ser indexado.
Enlaces SEO
Reescritura URL
Bien. Tus enlaces parecen amigables
Guiones bajos en las URLs
Perfecto! No hemos detectado guiones bajos en tus URLs
Enlaces en página
Hemos encontrado un total de 162 enlaces incluyendo 0 enlace(s) a ficheros
| Ancla | Tipo | Jugo |
|---|---|---|
| Solutions | Interna | Pasando Jugo |
| Portfolio management and asset valuation | Interna | Pasando Jugo |
| Early development and innovation | Interna | Pasando Jugo |
| Integrated clinical development | Interna | Pasando Jugo |
| Approval and access | Interna | Pasando Jugo |
| Value substantiation lifecycle management | Interna | Pasando Jugo |
| Delivery models | Interna | Pasando Jugo |
| Operational excellence | Interna | Pasando Jugo |
| Medical affairs | Interna | Pasando Jugo |
| Study start-up | Interna | Pasando Jugo |
| Overview | Interna | Pasando Jugo |
| Building patient insights into assets, profile and claims | Interna | Pasando Jugo |
| Portfolio optimization | Interna | Pasando Jugo |
| Asset valuation and indication prioritization | Interna | Pasando Jugo |
| Early evidence review | Interna | Pasando Jugo |
| Integrated development strategy and planning | Interna | Pasando Jugo |
| Phase I Clinical Trials | Interna | Pasando Jugo |
| Site Alliance Network and KOL Engagement | Interna | Pasando Jugo |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Interna | Pasando Jugo |
| Regulatory Strategy | Interna | Pasando Jugo |
| Real World Evidence | Interna | Pasando Jugo |
| Market Access Consulting, Strategy, and Delivery | Interna | Pasando Jugo |
| Biomarker and Genomic Medicine Strategy | Interna | Pasando Jugo |
| Integrated evidence generation planning | Interna | Pasando Jugo |
| Medical Communications | Interna | Pasando Jugo |
| Phase IIB-IV Clinical Trials | Interna | Pasando Jugo |
| Real World Evidence | Interna | Pasando Jugo |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Interna | Pasando Jugo |
| Protocol-Driven, Customized Site Solution Strategy | Interna | Pasando Jugo |
| Patient Inclusion | Interna | Pasando Jugo |
| Regulatory Strategy, Submissions, Compliance, and Outsourcing | Interna | Pasando Jugo |
| Market Access Strategy and Delivery | Interna | Pasando Jugo |
| Clinical Development Technology Optimization | Interna | Pasando Jugo |
| Clinical Trial Supply & Logistics | Interna | Pasando Jugo |
| Integrated evidence generation planning | Interna | Pasando Jugo |
| Medical Communications | Interna | Pasando Jugo |
| Drug Safety and Pharmacovigilance | Interna | Pasando Jugo |
| Global Regulatory Submissions and Outsourcing | Interna | Pasando Jugo |
| Real World Evidence | Interna | Pasando Jugo |
| Compliance and Risk Management | Interna | Pasando Jugo |
| Market Access Strategy and Delivery | Interna | Pasando Jugo |
| Integrated evidence generation planning | Interna | Pasando Jugo |
| Medical Communications | Interna | Pasando Jugo |
| Drug Safety and Pharmacovigilance | Interna | Pasando Jugo |
| Health economics modelling and simulation | Interna | Pasando Jugo |
| Real-World Evidence, Market Access Strategy and Planning | Interna | Pasando Jugo |
| Regulatory Compliance | Interna | Pasando Jugo |
| Lifecycle Optimization | Interna | Pasando Jugo |
| Integrated evidence generation planning | Interna | Pasando Jugo |
| Medical Communications | Interna | Pasando Jugo |
| Gain an advantage through FSP | Interna | Pasando Jugo |
| Leveraging AI in clinical development | Interna | Pasando Jugo |
| Medical affairs for clinical trials | Interna | Pasando Jugo |
| Biotech | Interna | Pasando Jugo |
| Listen Now | Interna | Pasando Jugo |
| Therapeutic Expertise | Interna | Pasando Jugo |
| Neuroscience | Interna | Pasando Jugo |
| General medicine | Interna | Pasando Jugo |
| Infectious disease and vaccines | Interna | Pasando Jugo |
| Immunology | Interna | Pasando Jugo |
| Oncology | Interna | Pasando Jugo |
| Hematology | Interna | Pasando Jugo |
| Cell and gene therapies | Interna | Pasando Jugo |
| Pediatrics | Interna | Pasando Jugo |
| Rare diseases | Interna | Pasando Jugo |
| Overview | Interna | Pasando Jugo |
| Cell and gene therapy | Interna | Pasando Jugo |
| Gastroenterology CRO | Interna | Pasando Jugo |
| Respiratory CRO | Interna | Pasando Jugo |
| Endocrine & Metabolic CRO | Interna | Pasando Jugo |
| Cardiovascular CRO | Interna | Pasando Jugo |
| Women's health CRO | Interna | Pasando Jugo |
| Critical Care | Interna | Pasando Jugo |
| Hepatitis B | Interna | Pasando Jugo |
| Novel treatments in infectious disease | Interna | Pasando Jugo |
| Ophthalmology CRO | Interna | Pasando Jugo |
| Dermatology CRO | Interna | Pasando Jugo |
| Allergy CRO | Interna | Pasando Jugo |
| Bladder cancer CRO | Interna | Pasando Jugo |
| Breast cancer CRO | Interna | Pasando Jugo |
| Gynecologic cancer CRO | Interna | Pasando Jugo |
| Head and neck cancer CRO | Interna | Pasando Jugo |
| Lung cancer CRO | Interna | Pasando Jugo |
| Phase I and rare tumors | Interna | Pasando Jugo |
| Prostate cancer CRO | Interna | Pasando Jugo |
| Neurology | Interna | Pasando Jugo |
| Psychiatry | Interna | Pasando Jugo |
| Pediatrics | Interna | Pasando Jugo |
| Rare Diseases | Interna | Pasando Jugo |
| Lymphoma CRO | Interna | Pasando Jugo |
| Acute myelogenous leukemia (AML) CRO | Interna | Pasando Jugo |
| Myelodysplastic syndrome (MDS) CRO | Interna | Pasando Jugo |
| Multiple Myeloma CRO | Interna | Pasando Jugo |
| Learn more | Interna | Pasando Jugo |
| Learn more | Interna | Pasando Jugo |
| Insights | Interna | Pasando Jugo |
| New frontiers in neuroscience | Interna | Pasando Jugo |
| Precision oncology | Interna | Pasando Jugo |
| Rare disease drug development | Interna | Pasando Jugo |
| Cell and gene therapy development | Interna | Pasando Jugo |
| Patient-guided drug development | Interna | Pasando Jugo |
| Clinical Trialblazers Podcast | Interna | Pasando Jugo |
| The Regulatory Navigator | Interna | Pasando Jugo |
| On The Pulse | Interna | Pasando Jugo |
| Learn more | Interna | Pasando Jugo |
| Learn more | Interna | Pasando Jugo |
| Participate | Interna | Pasando Jugo |
| Healthy volunteers | Interna | Pasando Jugo |
| Patient volunteers | Interna | Pasando Jugo |
| Patient advocacy groups | Interna | Pasando Jugo |
| Baltimore | Externo | Pasando Jugo |
| Los Angeles | Externo | Pasando Jugo |
| London | Externo | Pasando Jugo |
| Berlin | Externo | Pasando Jugo |
| Overview | Interna | Pasando Jugo |
| Advisory Council | Interna | Pasando Jugo |
| Patient stories | Interna | Pasando Jugo |
| Andrea & David's Story | Interna | Pasando Jugo |
| Stacy's Story | Interna | Pasando Jugo |
| Anisha's Story | Interna | Pasando Jugo |
| Rob's Story | Interna | Pasando Jugo |
| Learn more | Interna | Pasando Jugo |
| Sites | Interna | Pasando Jugo |
| Learn more | Interna | Pasando Jugo |
| About | Interna | Pasando Jugo |
| Leadership team | Interna | Pasando Jugo |
| Global reach | Interna | Pasando Jugo |
| Our inclusion strategy | Interna | Pasando Jugo |
| Our ESG strategy | Interna | Pasando Jugo |
| Compliance, tax & privacy | Interna | Pasando Jugo |
| Meet us at an event | Interna | Pasando Jugo |
| Overview | Interna | Pasando Jugo |
| Board of Directors | Interna | Pasando Jugo |
| Our ESG strategy | Interna | Pasando Jugo |
| Compliance & Ethics | Interna | Pasando Jugo |
| Tax Strategy | Interna | Pasando Jugo |
| Privacy Policy | Interna | Pasando Jugo |
| Cookies and other web tracking | Interna | Pasando Jugo |
| Supplier Data Privacy Requirements | Interna | Pasando Jugo |
| Terms of Use | Interna | Pasando Jugo |
| French Gender Pay Data | Interna | Pasando Jugo |
| UK Gender Pay Data | Interna | Pasando Jugo |
| UK Modern Slavery Act Statement | Interna | Pasando Jugo |
| Ireland Gender Pay Data | Interna | Pasando Jugo |
| Supplier Inclusion Policy | Interna | Pasando Jugo |
| Newsroom | Interna | Pasando Jugo |
| Academy | Externo | Pasando Jugo |
| Careers | Interna | Pasando Jugo |
| 中国 (China) | Interna | Pasando Jugo |
| 日本 (Japan) | Interna | Pasando Jugo |
| Contact Us | Interna | Pasando Jugo |
| Oncology | Interna | Pasando Jugo |
| Immunology | Interna | Pasando Jugo |
| Cell & Gene Therapy | Interna | Pasando Jugo |
| Endocrine & Metabolic | Interna | Pasando Jugo |
| See neuroscience capabilities | Interna | Pasando Jugo |
| Explore neuroscience careers | Interna | Pasando Jugo |
| biopharmaceutical leaders and sites | Interna | Pasando Jugo |
| Contact us | Interna | Pasando Jugo |
| My Communication Preferences | Interna | Pasando Jugo |
| Invoicing | Interna | Pasando Jugo |
| PO Terms and Conditions | Interna | Pasando Jugo |
Palabras Clave SEO
Nube de Palabras Clave
development strategy access clinical trials more cro overview patient medical
Consistencia de las Palabras Clave
| Palabra Clave (Keyword) | Contenido | Título | Palabras Claves (Keywords) | Descripción | Titulos |
|---|---|---|---|---|---|
| clinical | 55 |  |
|
|
 |
| cro | 50 | |
|
|
|
| overview | 44 | |
|
|
|
| development | 36 | |
|
|
|
| strategy | 30 | |
|
|
|
Usabilidad
Url
Dominio : parexel.com
Longitud : 11
Favicon
Genial, tu web tiene un favicon.
Imprimibilidad
No hemos encontrado una hoja de estilos CSS para impresión.
Idioma
Genial. Has declarado el idioma en.
Dublin Core
Esta página no usa Dublin Core.
Documento
Tipo de documento (Doctype)
HTML 5
Codificación
Perfecto. Has declarado como codificación UTF-8.
Validez W3C
Errores : 0
Avisos : 0
Privacidad de los Emails
Genial. No hay ninguna dirección de email como texto plano!
HTML obsoleto
Genial, no hemos detectado ninguna etiqueta HTML obsoleta.
Consejos de Velocidad
|
Excelente, esta web no usa tablas. |
|
Muy mal, tu web está usando estilos embenidos (inline CSS). |
|
Muy mal, tu página web usa demasiados ficheros CSS (más de 4). |
|
Muy mal, tu sitio usa demasiados ficheros JavaScript (más de 6). |
|
Su sitio web se beneficia del tipo de compresión gzip. ¡Perfecto! |
Movil
Optimización Móvil
|
Icono para Apple |
|
Etiqueta Meta Viewport |
|
Contenido Flash |
Optimización
Mapa del sitio XML
¡Perfecto! Su sitio tiene un mapa del sitio en XML.
| https://www.parexel.com/sitemap.xml |
Robots.txt
https://parexel.com/robots.txt
¡Estupendo! Su sitio web tiene un archivo robots.txt.
Herramientas de Analítica
No disponible
No hemos encontrado ninguna herramienta de analítica en esta web.
La analítica Web le permite medir la actividad de los visitantes de su sitio web. Debería tener instalada al menos una herramienta de analítica y se recomienda instalar otra más para obtener una confirmación de los resultados.
PageSpeed Insights
Dispositivo
Categorias
Free SEO Testing Tool
Free SEO Testing Tool es una herramienta seo gratuita que te ayuda a analizar tu web